Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-009067
Filing Date
2025-05-07
Accepted
2025-05-07 17:03:59
Documents
11

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 2120231
2 form424b3_001.jpg GRAPHIC 10244
3 form424b3_002.jpg GRAPHIC 90910
4 form424b3_003.jpg GRAPHIC 42067
5 form424b3_011.jpg GRAPHIC 27825
6 form424b3_012.jpg GRAPHIC 31022
7 form424b3_013.jpg GRAPHIC 47934
8 form424b3_014.jpg GRAPHIC 86641
9 form424b3_016.jpg GRAPHIC 14757
10 form424b3_017.jpg GRAPHIC 46295
11 form424b3_018.jpg GRAPHIC 33253
  Complete submission text file 0001641172-25-009067.txt   2716072
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280414 | Film No.: 25922605
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)